These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12649836

  • 1. [Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab].
    Kawachi Y, Ide M, Uchida T, Setsu K.
    Rinsho Ketsueki; 2003 Jan; 44(1):31-3. PubMed ID: 12649836
    [Abstract] [Full Text] [Related]

  • 2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 3. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH.
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [Abstract] [Full Text] [Related]

  • 4. [Effective treatment with rituximab in a patient with refractory idiopathic thrombocytopenic purpura].
    Tanai C, Iki S, Nakahara F, Iijima K, Usuki K, Kuwana M, Urabe A.
    Rinsho Ketsueki; 2004 Nov; 45(11):1181-6. PubMed ID: 15609684
    [Abstract] [Full Text] [Related]

  • 5. [Three cases of idiopathic thrombocytopenic purpura showing an increase in the platelet count following clarithromycin treatment].
    Ohe M, Kohno M.
    Rinsho Ketsueki; 2003 Oct; 44(10):1044-6. PubMed ID: 14639954
    [Abstract] [Full Text] [Related]

  • 6. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
    Wang W, Yu QH, Zhang HY, Chu XX, Chen F, Zhang CQ, Zhou YH, Hou M.
    Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
    [Abstract] [Full Text] [Related]

  • 7. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
    Latifzadeh SZ, Entezari V.
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
    Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB.
    Br J Haematol; 2004 Apr; 125(2):232-9. PubMed ID: 15059147
    [Abstract] [Full Text] [Related]

  • 9. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
    Riksen NP, Keuning JJ, Vreugdenhil G.
    Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
    Santos ES, Arosemena LR, Raez LE, O'Brien C, Regev A.
    Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
    [Abstract] [Full Text] [Related]

  • 11. [Rituximab treatment of chronic idiopathic thrombocytopenic purpura. Results of a phase II study].
    Meo P, Stipa E, La Presa M, Bianchi M, Di Giulio C, Stasi R, Amadori S.
    Recenti Prog Med; 2002 Jun; 93(7-8):421-7. PubMed ID: 12138687
    [Abstract] [Full Text] [Related]

  • 12. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 13. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
    Zhou Z, Yang R.
    Crit Rev Oncol Hematol; 2008 Jan; 65(1):21-31. PubMed ID: 17681784
    [Abstract] [Full Text] [Related]

  • 14. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
    Kuwana M, Iki S, Urabe A.
    Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
    [Abstract] [Full Text] [Related]

  • 15. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
    Zaja F, Battista ML, Pirrotta MT, Palmieri S, Montagna M, Vianelli N, Marin L, Cavallin M, Bocchia M, Defina M, Ippoliti M, Ferrara F, Patriarca F, Avanzini MA, Regazzi M, Baccarani M, Isola M, Soldano F, Fanin R.
    Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395
    [Abstract] [Full Text] [Related]

  • 16. B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
    Zaja F, Vianelli N, Sperotto A, De Vita S, Iacona I, Zaccaria A, Masolini P, Tomadini V, Tani M, Molinari AL, Baccarani M, Fanin R.
    Haematologica; 2003 May; 88(5):538-46. PubMed ID: 12745273
    [Abstract] [Full Text] [Related]

  • 17. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A, Catlett JP.
    South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
    [Abstract] [Full Text] [Related]

  • 18. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
    Thude H, Gruhn B, Werner U, Schorner U, Häfer R, Zintl F, Barz D.
    Acta Haematol; 2004 Oct; 111(4):221-4. PubMed ID: 15153715
    [Abstract] [Full Text] [Related]

  • 19. Rituximab treatment for symptomatic chronic ITP.
    Tamminga RY, Bruin MC.
    Pediatr Blood Cancer; 2006 Oct 15; 47(5 Suppl):714-6. PubMed ID: 16933264
    [Abstract] [Full Text] [Related]

  • 20. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
    Moschovi M, Trimis G, Pergantou H, Platokouki H, Vrachnou E, Tzortzatou-Stathopoulou F.
    J Paediatr Child Health; 2005 Jul 15; 41(7):384-6. PubMed ID: 16014149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.